Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy

AIDS. 2003 Mar 28;17(5):770-2. doi: 10.1097/00002030-200303280-00022.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anthropometry
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Female
  • Follow-Up Studies
  • HIV Infections / drug therapy
  • HIV-1
  • HIV-Associated Lipodystrophy Syndrome / chemically induced
  • HIV-Associated Lipodystrophy Syndrome / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Pioglitazone
  • Prospective Studies
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*

Substances

  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Pioglitazone